In all, clinical studies indicate that adult patients, with type 1 diabetes mellitus, are favoured by CSII treatment in comparison to MDI therapy and are led to a better glycaemic control with less hypoglycaemic episodes and insulin requirements [63]. Here, INS is linked to diabetes mellitus.